Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

1724studies indexed776with human data107registered trials1479carry a numeric findingLibrarian added 0 studies today

Showing 4 studiesSortNewest indexed ▾

grade

Influence of manufacturing protocol, polishing, and thermocycling on water contact angle and hardness of zirconia: Comparison of additive and subtractive techniques.

Tri-Heal Max Protocol · The Journal of prosthetic dentistry · 2026 · Observational

The manufacturing protocol significantly affects the water contact angle and hardness of zirconia, especially before polishing, but differences diminish after polishing.

P<.001 for interaction between manufacturing protocol and processing stage.

summary

Full text read

Source →

grade

A dried blood spot protocol for high-throughput semi-quantitative analysis of Epstein-Barr Virus VCA IgG and EBNA IgG serologies based on the Roche Elecsys system.

Tri-Heal Max Protocol · Virology journal · 2026 · Observational

The study established a high-throughput DBS protocol for EBV antibody detection, achieving 98.8% sensitivity and 96.5% specificity compared to serum assays.

98.8% sensitivity of DBS relative to serum results.

summary

Full text read

Source →

grade

Endoscopic Lumbar Discectomy in Professional Athletes: A Case Series and Structured Rehabilitation Protocol Enabling Rapid Return to Play.

Tri-Heal Max Protocol · PubMed · 2026 · Observational

FELD combined with a structured rehabilitation protocol may allow professional athletes to return to play in about 3.4 months, with 80% resuming their preinjury performance levels.

Mean RTP time was 3.4 months, n=20.

summary

Full text read

Source →

grade

Precise Epithelium Removal for Ectatic Corneas Technique in Corneal Collagen Crosslinking (PERFECT-CXL): Technique Description and Clinical Outcomes.

Tri-Heal Max Protocol · PubMed · 2026 · Observational

PERFECT-CXL showed stable visual acuity in over 94% of eyes at three years, with minimal progression requiring retreatment, but further research is needed to validate these results.

BSCVA stable in 97.5% (n=120) at 6 months, p<0.001.

summary

Full text read

Source →

Showing 4 of 4